Loading…

Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue

RNA biomarkers discovered by RT-PCR-based gene expression profiling of archival formalin-fixed paraffin-embedded (FFPE) tissue form the basis for widely used clinical diagnostic tests; however, RT-PCR is practically constrained in the number of transcripts that can be interrogated. We have developed...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2012-07, Vol.7 (7), p.e40092-e40092
Main Authors: Sinicropi, Dominick, Qu, Kunbin, Collin, Francois, Crager, Michael, Liu, Mei-Lan, Pelham, Robert J, Pho, Mylan, Dei Rossi, Andrew, Jeong, Jennie, Scott, Aaron, Ambannavar, Ranjana, Zheng, Christina, Mena, Raul, Esteban, Jose, Stephans, James, Morlan, John, Baker, Joffre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:RNA biomarkers discovered by RT-PCR-based gene expression profiling of archival formalin-fixed paraffin-embedded (FFPE) tissue form the basis for widely used clinical diagnostic tests; however, RT-PCR is practically constrained in the number of transcripts that can be interrogated. We have developed and optimized RNA-Seq library chemistry as well as bioinformatics and biostatistical methods for whole transcriptome profiling from FFPE tissue. The chemistry accommodates low RNA inputs and sample multiplexing. These methods both enable rediscovery of RNA biomarkers for disease recurrence risk that were previously identified by RT-PCR analysis of a cohort of 136 patients, and also identify a high percentage of recurrence risk markers that were previously discovered using DNA microarrays in a separate cohort of patients, evidence that this RNA-Seq technology has sufficient precision and sensitivity for biomarker discovery. More than two thousand RNAs are strongly associated with breast cancer recurrence risk in the 136 patient cohort (FDR
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0040092